Crispr Therapeutics, Inc. 401(k) Plan: Login, Facts & Contact Information

Crispr Therapeutics, Inc. 401(k) Plan Facts

Plan name
CRISPR THERAPEUTICS 401(K) RETIREMENT PLAN
Plan type
401(k) with employer contributions and profit sharing
Plan sponsor
CRISPR THERAPEUTICS, INC.
Participants
630 (398 active employees)
Former employees with a balance
220
Plan assets
$66,700,833 at Dec 31, 2024
Average account balance
$109,525 across 609 accounts
Employer contributions
$2,649,653 in plan year 2024 (27% of all contributions)
Recordkeeper
Fidelity Investments Institutional
Plan year
Jan 1, 2024 – Dec 31, 2024
Plan established
Nov 1, 2016
✓ Employer contributions✓ Automatic enrollment✓ Default investment for undecided participants✓ Participants choose their own investments— Self-directed brokerage window✓ Profit sharing— Company stock (ESOP)

Source: Form 5500 for plan year 2024 (Jan 1, 2024 – Dec 31, 2024), filed Sep 19, 2025. Public filing with the U.S. Department of Labor.

Money in and out in plan year 2024

  • $9.95 million went into the plan in contributions, $2.65 million of it from the employer (27%).
  • $5.93 million was paid out to participants.
  • Investment and other income added $8.77 million.

How the Crispr Therapeutics, Inc. 401(k) changed, 2019–2024

Plan yearParticipantsPlan assetsEmployer contributionsBenefits paid
2019195$11.4 million$1.01 million$526,593
2020343$21.6 million$1.91 million$1.34 million
2021509$35.8 million$2.64 million$2.07 million
2022597$37.6 million$3.67 million$3.19 million
2023614$53.8 million$2.91 million$3.05 million
2024630$66.7 million$2.65 million$5.93 million

Crispr Therapeutics, Inc. 401(k) Contact Information

Phone
617-315-4600
Mailing address
105 W. FIRST ST., BOSTON MA 02127
Plan sponsor
CRISPR THERAPEUTICS, INC.
Employer identification number (EIN)
47-3173478
Plan number
001

Questions about the Crispr Therapeutics, Inc. 401(k)

Does Crispr Therapeutics, Inc contribute to the 401(k)?

Yes. The plan reports an employer contribution arrangement. In plan year 2024 the employer contributed $2.65 million, 27% of all contributions.

Does the Crispr Therapeutics, Inc 401(k) have automatic enrollment?

Yes. The plan reports automatic enrollment of eligible employees.

How many people are in the Crispr Therapeutics, Inc 401(k) plan?

630 participants at the start of plan year 2024, 398 of them active employees, and 220 former employees who still had money in the plan.

What is the average 401(k) balance at Crispr Therapeutics, Inc?

About $109,525 per account: $66.7 million in plan assets across 609 accounts with a balance at the end of plan year 2024.

Who manages the Crispr Therapeutics, Inc 401(k) accounts?

Fidelity NetBenefits (listed on the filing as FIDELITY INVESTMENTS INSTITUTIONAL) is the plan's recordkeeper, which is where participants log in to see their balance.

I no longer work at Crispr Therapeutics, Inc. How do I access my 401(k)?

Your account stays with Fidelity NetBenefits after you leave, so you can log in with the same credentials. If your balance was small, the plan may have rolled it into an IRA in your name. If you can't find it, Beagle can locate it for you.

Related Companies
Headquarter: 3180 PULLMAN ST, COSTA MESA, CA, 926263323
Headquarter: 38905 10TH STREET E., PALMDALE, CA, 935503415
Headquarter: 121 ALBRIGHT WAY, LOS GATOS, CA, 95032
Headquarter: 421 FAYETTEVILLE ST. SUITE 600, RALEIGH, NC, 27601
Headquarter: 300 CHESTNUT RIDGE ROAD, WOODCLIFF LAKE, NJ, 07677